Holdings
ADAR1 Capital Management, LLC
As of Jun 30, 2026, ADAR1 Capital Management, LLC reported 223 positions worth US$1.86B. Largest: Abivax Sa, Protagonist Therapeutics, Inc. and Roivant Sciences Ltd. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Abivax Sa | 1.8M | US$240M | +411K | Jun 30, 2026 |
| Protagonist Therapeutics, Inc. | 961K | US$118M | −33,256 | Jun 30, 2026 |
| Roivant Sciences Ltd. | 3.16M | US$112M | −129K | Jun 30, 2026 |
| Immunovant, Inc. | 2.33M | US$89.8M | −348K | Jun 30, 2026 |
| Zai Lab Ltd. | 3.37M | US$64M | +1.94M | Jun 30, 2026 |
| Agios Pharmaceuticals, Inc. | 1.29M | US$47.8M | +1.15M | Jun 30, 2026 |
| Crinetics Pharmaceuticals, Inc. | 1.22M | US$45.7M | +82,749 | Jun 30, 2026 |
| Cytokinetics, Incorporated | 458K | US$39M | −175K | Jun 30, 2026 |
| Septerna, Inc. | 941K | US$31.5M | −149K | Jun 30, 2026 |
| Anteris Technologies Global Corp. | 3.15M | US$31M | −644K | Jun 30, 2026 |